Coronary artery vitamin D receptor expression and plasma concentrations of 25-hydroxyvitamin D: Their association with atherosclerosis

Menopause

Volumn 19, Issue 9, 2012, Pages 967-973

  Schnatz, Peter F ^a,b   Nudy, Matthew ^a,b   O'Sullivan, David M ^a   Jiang, Xuezhi ^a   Mark Cline, J ^c   Kaplan, Jay R ^c   Clarkson, Thomas B ^c   Appt, Susan E ^c  

^a READING HOSPITAL AND MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cardioprotection; Coronary artery atherosclerosis; Coronary heart disease; Menopause; Vitamin D; Vitamin D receptors

Indexed keywords

25 HYDROXYVITAMIN D; CASEIN; COLECALCIFEROL; LACTALBUMIN; SOYBEAN PROTEIN; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CIRCUMFLEX BRANCH; DIET; FEMALE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; OBESITY; PREMENOPAUSE; PROTEIN EXPRESSION;

ANIMALS; CHOLECALCIFEROL; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIET, ATHEROGENIC; FEMALE; MACACA FASCICULARIS; OVARIECTOMY; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 84865725758     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31824cfa8f     Document Type: Article

References (55)

1. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:10805-10865.
2. Perez-Lopez FR. Vitamin D: secosteroid hormone and reproduction. Gynecological Endocrinology 2006;22:1-12.
3. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281.
4. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80:1689-1696.
5. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116:2062-2072.
6. Hollis BW. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int 1996;58:4-5.
7. Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds); Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Available at: http://books.nap.edu/openbook.php?record-id=13050&page=R1. Accessed December 15, 2011.
8. Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-261.
9. Holick MF. Clinical efficacy of 1,25-dihydroxyvitamin D3 and its analogues in the treatment of psoriasis. Retinoids 1998;14:12-17.
10. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296:2832-2838.
11. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-511.
12. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 2008;168: 1174-1180.
13. Wong MS, Delansorne R, Man RY, Vanhoutte PM. Vitamin D derivatives acutely reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2008;295:H289-H296.
14. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386: 78-81.
15. Canning MO, Grotenhuis K, de Wit H, et al. 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 2001;145:351-357.
16. Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002;95:787-796.
17. Manson JE, Bassuk SS. Vitamin D and cardiovascular disease. Menopause Manage 2009;18:28-31.
18. Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 1986;119:84-90.
19. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980;209:823-825.
20. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficientVa randomised, placebocontrolled trial. Br J Nutr 2010;103:549-555.
21. Pittas AG, Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol 2010;121:425-429.
22. Mathieu C, Waer M, Laureys J, et al. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994;37: 552-558.
23. Gregori S, Giarratana N, Smiroldo S, et al. A 1,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002;51:1367-1374.
24. Gysemans CA, Cardozo AK, Callewaert H, et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005;146:1956-1964.
25. Hatton DC, Xue H, DeMerritt JA, McCarron DA. 1,25(OH)2 vitamin D3-induced alterations in vascular reactivity in the spontaneously hypertensive rat. Am J Med Sci 1994;307:S154-S158.
26. Li YC, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine regulator of the reninangiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004;89-90:387-392.
27. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110:229-238.
28. Maiya S, Sullivan I, Allgrove J, Yates R, Malone M, et al. Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart 2008;94:581-584.
29. Weber KT, Simpson RU, Carbone LD. Vitamin D and calcium dyshomoeostasis-associated heart failure. Heart 2008;94:540-541.
30. Aihara K, Azuma H, Akaike M, et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004;279:35798-35802.
31. Hunter D, De Lange M, Snieder H, et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 2001;16:371-378.
32. Karohl C, Su S, Kumari M, et al. Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr 2010;92: 1393-1398.
33. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010;376:180-188.
34. Cherniack EP, Florez HJ, Hollis BW, Roos BA, Troen BR, Levis S. The response of elderly veterans to daily vitamin D3 supplementation of 2,000 IU: a pilot efficacy study. J Am Geriatr Soc 2011;59:286-290.
35. Vashi PG, Trukova K, Lammersfeld CA, Braun DP, Gupta D. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutr J 2010;9:60.
36. Schnatz PF, Nudy M, O'Sullivan DM, Ethun K, Appt SE, Clarkson TB. Identification of a mechanism for increased cardiovascular risk among individuals with low vitamin d concentrations. Menopause 2011;18: 994-1000.
37. Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 2008;149:3656-3667.
38. Wu-Wong JR. Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol 2009;158:395-412.
39. Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am Physiol Soc 1994;267:E356-E360.
40. Menezes RJ, Cheney RT, Husain A, et al. Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue. Cancer Epidemiol Biomarkers Prev 2008;17:1104-1110.
41. Chen S, Glenn DJ, Ni W, et al. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension 2008;52:1106-1112.
42. Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004;19:265-269.
43. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1, hydroxylase in human brain. J Chem Neuroanat 2005;29:21-30.
44. Langub MC, Reinhardt TA, Horst RL, Malluche HH, Koszewski NJ. Characterization of vitamin D receptor immunoreactivity in human bone cells. Bone 2000;27:383-387.
45. Dokoh S, Donaldson CA, Marion SL, Pike JW, Haussler MR. The ovary: a target organ for 1,25-dihydroxyvitamin D3. Endocrinology 1983;112: 200-206.
46. Lewis JG, Elder PA. Serum 25-OH vitamin D2 and D3 are stable under exaggerated conditions. Clin Chem Acta 1960;5:609-617.
47. Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effect of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 2001; 86:41-47.
48. Weigert C.Ü ber eine Methode zur Färbung elastischer Fasern. Zentralblatt für Allgemeine Pathologie, und Pathologische Anatomie 1898;9:289-292.
49. Siboni A, Mourits-Andersen T, Moesner J. Granulomatous bone marrow inflammation during treatment of chronic myeloid leukaemia with interferon 2b. J Clin Pathol 1995;48:878-880.
50. Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998;13:325-349.
51. Sutton AL, MacDonald PN. Vitamin D: more than a Fbone-a-fide hormone. Mol Endocrinol 2003;17:777-791.
52. Pike JW, Shevde NK. The vitamin D receptor. In: Feldman D, Pike JW, Glorieux F, eds. Vitamin D, 2nd ed. New York, NY: Elsevier/Academic Press; 167-191.
53. Zwerina K, Baum W, Axmann R, et al. Vitamin D receptor regulates TNF-mediated arthritis. Ann Rheum Dis 2011;70:1122-1129.
54. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29:726-776.
55. Schnatz, PF, Nudy M, O'Sullivan DM, et al. The quantification of vitamin D receptors in the coronary vasculature and association with atherosclerosis. Menopause 2011;18:1345.